The Selective Proteasome Inhibitor Carfilzomib Is Well Tolerated in Experimental Animals with Dose Intensive Administration

Autor: Kirk, Christopher J *, Jiang, Jing *, Muchamuel, Tony *, Dajee, Maya *, Swinarski, Deborah *, Aujay, Monette *, Bennett, Mark K *, Yang, Jinfu *, Lewis, Evan *, Laidig, Guy *, Molineaux, Christopher J.
Zdroj: In Blood 16 November 2008 112(11):2765-2765
Databáze: ScienceDirect